pathology of breast disease Flashcards

(73 cards)

1
Q

normal structure of the breast - lobes and lobules

A

each breast has 8-10 lobes (arranged like daisy petals)
inside each lobe are smaller structures called lobules
at the end of each lobule are bulbs that can produce milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

changes to breasts in puberty - ducts

A

before puberty - breasts in both sexes, ducts

variable degrees of branching, lack lobules
15-25 lactiferous ducts
start at the nipple and branch until terminal ductal lobular unit
hormonally responsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

lymph ducts in the breast

A

drain fluid carrying WBCs fromt he breast tissue into LNs in the axilla and behind the sternum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lymph nodes in the breasts

A

filter harmful bacteria

play a key role in fighting off infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

give 5 examples of benign breast conditions

A
fibrocystic change 
fibroadenoma 
intraduct papilloma - lactiferous ducts, nipple discharge
fat necrosis - traumatic
duct ectasia - nipple discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

examples of fibrocystic change

A
fibrosis 
adenosis 
cysts 
apocrine metaplasia 
ductal epithelial hyperplasia (usal type, atypical)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a fibroadenoma

A

well circumscribed, freely mobile, non-painful mass

proliferation of epithelial and stromal elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how common are fibroadenomas

A

most common breast tumour in adolescent and young adult women

peak age - 3rd decade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can happen to fibroadenomas if untreated

A

may regress with age if left untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

growth pattern in fibroadenomas

A

ducts distorted and elongated –> slit like structures, intracanalicular pattern, ducts not compressed –> pericanalicular growth pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

intraductal papilloma

  • who
  • key symptom
  • features
A

usually middle aged women
nipple discharge
can show epithelial hyperplasia which may be atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fat necrosis - what can it result in

A

can stimulate carcinoma - clinically and mammographically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what causes fat necrosis

A

hx of antecedent trauma, prior to surgical intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

histological features of fat necrosis

mammography features

A

histiocytes with foamy cytoplasm
lipid-filled cysts

fibrosis, calcifications, egg shell on mammography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Phyllodes tumour

A

fleshy tumour, leaf like pattern and cysts on cut surface

circumscribed, connective tissue and epithelial elements

1-15cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how common are Phyllodes tumour

A

<1% of breast tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what type of tumours are Phyllodes tumour

what about the mets

A

benign, borderline, malignant

mets are hematogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

breast cancer incidence

A

2.3mln new cases 2020
incidence increasing in most countries
685 000 deaths
commonest cancer in UK (15%)

55200 new cases p/a UK, 4700 scotland

390 male breast cancer p/a UK, 31 scotland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

risk factors for breast cancer

A
gender
age 
menstrual hx
age at 1st pregnancy
radiation
FHx
personal hx
hormonal treatment
genetics
other: obesity, lack of physical activity, alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

causes of hereditary susceptibility to breast cancer

gene, contribution to hereditary breast cancer

A
BRCA1 20-40%
BRCA2 10-30%
TP53 <1%
PTEN <1%
other 30-70%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

histological classification of breast cancer

A

non-invasive

invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

non-invasive breast cancers

A

ductal carcinoma in situ (DCIS)

lobular carcinoma in situ (LCIS/LISN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

invasive breast cancers

A
invasive no special type (ductal) carcinoma, NST (~75%)
special types (rest) incl. invasive lobular carcinoma and variants (5-15%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

features of in situ carcinoma

A
pre-invasive - no palpable tumour formed
not detected clinically - only x-ray in DCIS screening 
multi centricity and bilaterality (LCIS)
no mets - basement membrane 
risk of invasion depending on grade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
in situ cancer - risk of progression
low grade DCIS - 30% in 15yrs high grade DCIS - 50% in 8yrs LCIS - 19% in 25yrs and bilaterality
26
histological classification - pure special types
``` >90% of tumour showing characteristic features of a specific type: tubular carcinoma cribiform carcinoma mucinous carcinoma carcinoma w/ medullary features metaplastic carcinoma others ```
27
histological classification - NST and mixed carcinoma
NST carcinoma - up to 75% of cases invasive tumour shows none of <50% of special type features mixed carcinoma: heterogenous morphology 50-<90% special type morphology
28
what is shown
normal breast tissue
29
what is shown
normal breast tissue
30
what is shown
involution - progressive decrease in the size of an organ usually associated with a decline in function
31
what cells can be seen here
epithelial and myoepithelial cells
32
what type of change can be seen here
fibrocystic change
33
what tumour type is shown here
fibroadenoma
34
what tumour type is shown here
intraductal papilloma
35
what change is shown here
fat necrosis
36
what tumour type is shown here
Phyllodes tumour
37
what carcinoma is shown here
LCIS
38
what carcinoma type is shown here
NST carcinoma
39
what grade would this carcinoma be
3
40
what carcinoma is shown here
ILC
41
what carcinoma is shown here
tubular carcinoma
42
what carcinoma type is shown here
tubular carcinoma
43
what carcinoma type is shown here
medullary
44
what carcinoma type is shown here
mucinous
45
what carcinoma type is shown here
micropapillary
46
diagnostic procedures for breast cancer
``` clinical examination radiology - mammogram, US, MRI FNA cytology needle core biopsy diagnostic excision ```
47
what is included in the histology report
``` invasive vs non-invsaive histological type - ductal (85%) vs lobular grade - estimate of aggressiveness under microscope size margins LNs estrogen/progesterone receptor (2/3 +ve) HER-2/neu ```
48
how can breast cancer spread
local - skin, pectoral muscles lymphatic - axillary and internal mammary nodes blood - bone, lungs, liver, brain
49
spread of breast cancer - what is shown here
LVSI Lymphovascular space invasion
50
spread of breast cancer - what is shown here
LN mets
51
determining prognosis of breast cancer
``` patient related and tumour related node status - best prognostic indicator tumour size (<2cm) type grade (1,2,3) age lymphovascular space invasion oestrogen receptors (ER), progesterone receptors (PR) HER-2 proliferative rate of tumour gene expression profiling NPI - tumour size, grade, nodal status ```
52
what is the overall 5YS for breast cancer
64%
53
molecular markers for breast cancer and clinical applications
ER/PR - strong predictors of response to hormonal therapies ER/PR-ve tumours do NOT respond HER-2: ~20-30% +ve, predicts response to trastuzumab (herceptin)
54
what is shown here
oestrogen receptors
55
what is shown here
HER-2
56
molecular classification of cancers
gene expression technology 5 subtypes biologically diverse disease predictive gene signatures/potential to improve therapy complement current clinicopathological features
57
molecular classification - what are the 5 subtypes
``` ER+ luminal A lumina B basal HER 2+ normal breast like ```
58
luminal A features and prevalence
ER +ve HER 2 -ve low Ki67 55%
59
luminal B features and prevalence
ER+ve HER2 +ve (or -ve w/ high Ki67) 15%
60
triple -ve/basal like features and prevalence
ER -ve PR -ve HER2 -ve 10-15%
61
HER2 type features and prevalence
ER -ve PR -ve HER2 +ve 15-20%
62
what is true recurrence
carcinoma survives initial treatment and recurs
63
what is a new 1y
a 2nd cancer which is biologically different from 1st cancer
64
what % of breast cancer patients will develop a 2nd cancer
~10% of pts undergoing breast conservation for breast cancer will develop a 2nd cancer within 10yrs <10yrs - majority are true recurrences 10 yrs - 50/50 >10yrs - majority are new 1ys
65
when is the incidence of recurrence more
more in triple -ve breast cancer compared to ER or HER2 +ve cancers
66
prognosis with true recurrence
poorer prognosis that new 1ys (depending on stage of new cancer) pathological features are inaccurate in 40%
67
what is Paget's disease of the nipple
result of intraepithelial spread of intraductal carcinoma
68
histological features of Paget's disease of the nipple
large pale staining cells within the epidermis of the nipple
69
clinical features of Paget's disease of the nipple
limited to the nipple or can extend to the areola pain/itching, scaling, redness - mistaken for eczema ulceration, crusting, serous/bloody discharge
70
what is shown here
Paget's disease
71
gynaecomastia
most common clinical and pathologic abnormality of the male breast increase in subareolar tissue in 30-40% of adult males, both breasts are affected in many cases
72
what is gynaecomastia associated with
``` hyperthyroidism liver cirrhosis chronic renal failure chronic pulmonary disease hypogonadism use of hormones - oestrogens, androgens drugs - digitalis, cimetidine, spironolactone, marijuana, tricyclic antidepressants ```
73
carcinoma of the male breast prevalence
uncommon | <1% of all breast cancers